Effects of Bisoprolol Are Comparable with Carvedilol in Secondary Prevention of Acute Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention

Seung Jin Jun(Chonnam National University Hospital), Young Keun Ahn(Chonnam National University Hospital), Doo Sun Sim(Chonnam National University Hospital), Ju Han Kim(Chonnam National University), Hun Sik Park(Kyungpook National University Hospital), Jei Keon Chae(Chonnam National University), Min Chul Kim(Chonnam National University), Jong Sun Park(Seoul National University Hospital), Myung Ho Jeong(Veterans Health Service Medical Center), Young Joon Hong(Chonnam National University Hospital), Kyung Hwan Kim(Jeju National University), Myeong‐Chan Cho(Korea National Institute of Health)
Chonnam Medical Journal
January 1, 2018
10.4068/cmj.2018.54.2.121
Cited by 6

Related Papers

Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
|New England Journal of Medicine|2010|510
Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
|New England Journal of Medicine|2008|493
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial
|The Lancet|2018|372
Clinical Impact of Intravascular Ultrasound–Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation
|Circulation Cardiovascular Interventions|2015|304
Long-Term Safety and Efficacy of Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease
|Journal of the American College of Cardiology|2010|278